Lorraine is a former registered nurse with over 25 years of experience in the Canadian public health care system and biopharmaceutical industry. Her experience spans sales, marketing, market access, government relations and patient advocacy.
Therapeutic areas of experience and expertise include:
- Neurology: multiple sclerosis and the rare disease, spinal muscular atrophy (SMA) and Alzheimer’s Disease
- Hematology: hemophilia and anemia
- Oncology: neuro and dermatologic, supportive care
- Critical care
Lorraine’s strengths include integrating the patient and clinician perspective along with the clinical and economic value proposition to address payer information requirements for reimbursement decision making. She believes that the patient community perspective and integrating the community voice is a critical element for a successful strategy.
In the Canadian environment, resource challenges and competing funding priorities require novel approaches for a successful health technology assessment and reimbursement strategy.
Lorraine’s expertise has evolved with the development of creative approaches for new innovations that face uncertain health technology assessment and reimbursement pathways. She has partnered with patient, clinician and payer stakeholders to build mutually acceptable solutions for successful reimbursement outcomes.